Determination of cadmium speciation uptake by vetiver grass (Vetiveria nemoralis. A.Camus) K. Jampasri, A. Kumsopa, University of Mahidol, Bangkok/T |
|
Investigating aglycone maturation in glycopeptide antibiotic biosynthesis M. Peschke, K. Haslinger, C. Brieke, M.J. Cryle, MPI for Medical Research, Heidelberg/D |
|
Synthesis and modifications towards Crocapeptin A C. Wuttke, U. Kazmaier, University of Saarland, Saarbrücken/D |
|
The structure of CotB2 a bacterial diterpene cyclase is reported. Plasticity residues have been mutated resulting in new, bioactive products R. Janke, FU Berlin/D; C. Görner, M. Hirte, T. Brück, TU München, Garching/D; B. Loll, FU Berlin/D |
|
Affinity matrices for chemical proteomics G. Médard, B. Kuster, University of Munich, Freising/D |
|
Towards the discovery of a selective EPHA2 inhibitor S. Heinzlmeir, G. Medard, University of Munich, Freising/D; K. Saxena, H. Schwalbe, University of Frankfurt/D; B. Kuster, University of Munich, Freising/D |
|
Generic cell-permeable probes of eukaryotic and bacterial sialyl transferases: new targets in inflammation and cancer? J.J. Preidl, University of Berlin/D; V.S. Gnanapragassam, R. Horsttkorte, University of Halle-Wittenberg/D; J. Rademann, University of Berlin/D |
|
The biosynthesis of albicidin D. Petras, A. Mainz, TU Berlin/D; S. Cociancich, M. Royer, CIRAD UMR BGPI, Montpellier/F; R.D. Süssmuth, TU Berlin/D |
|
Wnt signaling inhibition by withanolide-inspired small molecules:β-catenin on a rollercoaster ride S. Kapoor, M. Sheremet, S. Sievers, S. Ziegler, K. Kumar, H. Waldmann, Max Planck Institute of Molecular Physiology, Dortmund/D |
|
Development of a STAT5 inhibitor as potential therapeutic approach for acute Myeloid Leukemia E. Wong, FU Berlin/D; B. Kim, Leibniz Institut für Molekulare Pharmakologie (FMP), Berlin/D; E. Nawrotzky, C. Arkona, FU Berlin/D; S. Beligny, M. Lisurek, D. Carstanjen, Leibniz Institut für Molekulare Pharmakologie (FMP), Berlin/D; J. Rademann, FU Berlin/D |
|
Employing the enone functionality to modulate biological activity N. Al-Rifai, M. Enzinger, A. Rasras, H. Rücker, S. Amslinger, University of Regensburg/D |
|
Novel, highly selective benzoxazepine-type inhibitors for the CREBBP/EP300 bromodomains F. Bracher, T.A. Popp, University of Munich/D; O. Fedorov, C. Tallant, S. Knapp, SGC Oxford/UK |
|
Natural product inspired compound collection emphasizes the MAP4K4 connection to neuritogenesis P. Schröder, T. Förster, S. Ziegler, K. Kumar, H. Waldmann, Max Planck Institute of Molecular Physiology, Dortmund/D |
|
Distinct signaling requirements for the establishment of naïve pluripotency in chemical reprogramming of late-stage epiblast stem cells D.J. Illich, M. Zhang, Max Planck Institute for Molecular Biomedicine, Münster/D; A. Ursu, Max Planck Institute of Molecular Physiology, Dortmund/D; R. Osorno, G. Wu, D. Esch, K. Adachi, D. Sabour, M. Stehling, S. Höing, Max Planck Institute for Molecular Biomedicine, Münster/D; S. Ziegler, H. Waldmann, Max Planck Institute of Molecular Physiology, Dortmund/D; H.R. Schöler, Max Planck Institute for Molecular Biomedicine, Münster/D |
|
Multivalent DOTAM derivatives for bacteria theranostic applications H.-Y. Hu, B. Rais, N. Meier, G. Sergeev, P. P. Müller, M. Brönstrup, Helmholtz Center for Infection Research, Braunschweig/D |
|
The Compound Management and Screening Center of the Max Planck Society (COMAS) G. Hahne, S. Sievers, Max Planck Institute of Molecular Physiology, Dortmund/D |
|
Transition-metal-mediated uncaging in living human cells - an emerging alternative to photolabile protecting groups T. Völker, E. Meggers, Universität Marburg/D |
|
Total synthesis and absolute configuration of epicoccamide D, a naturally occurring mannosylated 3-acyltetramic acid S. Loscher, R. Schobert, University of Bayreuth/D |
|
Multivalent peptide-conjugates to address viral interactions M. Glanz, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D; D. Lauster, Humboldt-Universität zu Berlin/D; M. Hellmund, K. Ludwig, C. Böttcher, R. Haag, FU Berlin/D; A. Herrmann, Humboldt-Universität zu Berlin/D; C.P.R. Hackenberger, Leibniz-Institut für Molekulare Pharmakologie (FMP), Berlin/D |
|
Formation of inhibitors of factor Xa via template-assisted fragment-ligation reactions M. Jaegle, J. Rademann, FU Berlin/D |
|
Structural and biochemical characterization of the human soluble adenylyl cyclase S. Kleinbölting, C. Steegborn, University of Bayreuth/D |
|
A click-chemistry approach toward JAK3-selective ruxolitinib analogs M. Gehringer, M. Forster, S. Laufer, University of Tübingen/D |
|
nach oben |